Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ectoin Mouth Wash for Radiation-Induced Oral Mucositis
NCT03932292Completed
- Sponsor
- bitop AG
- Start
- Dec 2018
- Primary completion
- Oct 2019
- Modality
- Bivalent/Multivalent Binders, Allosteric Modulators, Molecular Glues
- Countries
- 1
01
Overview
Open-label trial of ectoin in oral mucositis (OM) (2 arms), sponsored by bitop AG. Primary endpoints: Change in degree of mucositis (WHO classification) and Change in mucositis symptoms. Started Dec 2018; status: completed.
02
Drugs
ectoin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03932292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03932292.